Navigation Links
Mast Therapeutics Presents MST-188 Data at 7Th Annual Sickle Cell Disease Research and Educational Symposium
Date:4/17/2013

ase, acute limb ischemia, and blood transfusions, as well as the timing of activities related to those plans, and prospects for MST-188's clinical, regulatory and commercial success.  Among the factors that could cause or contribute to material differences between the Company's actual results and expectations indicated by the forward-looking statements are risks and uncertainties that include, but are not limited to: the uncertainty of outcomes in ongoing and future nonclinical and clinical studies despite positive results in nonclinical testing and prior clinical studies; the potential for significant delays in the development of MST-188, including due to lack of funding, delays in the commencement or completion of clinical studies, including as a result of difficulties in obtaining regulatory agency agreement on clinical development plans or clinical study design, opening trial sites, enrolling study subjects, manufacturing sufficient quantities of clinical trial material, completing necessary manufacturing process development activities, and being subject to a "clinical hold," or suspension or termination of a clinical study, including due to patient safety concerns; the potential for institutional review boards or the FDA or other regulatory agencies to require additional nonclinical or clinical studies prior to initiation of planned phase 2 clinical studies of MST-188 in any particular indication in which the Company determines to develop MST-188, including acute limb ischemia, which likely would increase the total time and cost of development in the indication; the risk that clinical studies of MST-188 are not successfully executed and/or do not successfully demonstrate its safety or efficacy; the risk that, even if clinical studies are successful, the FDA or other regulatory agencies may determine they are not sufficient to support a new drug application; the risk that even if clinical studies of MST-188 in one indication or jurisdiction are successful,
'/>"/>
SOURCE Mast Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Society for Brain Mapping and Therapeutics (SBMT) announce the formation of American Board of Brain Mapping, its 2013 award recipients and its Brain Mapping Day at the US Congress
2. Sorbent Therapeutics Initiates Phase 2b Clinical Trial of CLP-1001 for Treatment of Signs and Symptoms of Fluid Overload in Patients with Heart Failure
3. NewGen Therapeutics Presents Data on NT-113, A Novel Pan-ErbB Inhibitor, at American Association of Cancer Research
4. Sorrento Therapeutics, Inc. and IGDRASOL Announce Presentation on Non-Biologic Nanoparticle paclitaxel (NBN-Pac) Formulations for the Treatment of Solid Tumors at the Nanomedicine 2013 Meeting in Barcelona, Spain
5. Spencer Trask Congratulates InVivo Therapeutics on its Recent Approvals from the FDA
6. Zacks Industry Outlook Highlights: Eli Lilly, Novo Nordisk, Biogen, Amgen and Osiris Therapeutics
7. Adenosine Therapeutics Engages Needham & Company to Explore Strategic Options for Phase III Cardiac Stress Agent
8. Halozyme Therapeutics Names Matt Posard to Board of Directors
9. Mast Therapeutics Engages ESC Advisors To Identify Partnering Opportunities For MST-188
10. Cell Therapeutics Secures $15 Million Loan Financing Agreement
11. United Therapeutics Announces Receipt Of Second Complete Response Letter For Oral Treprostinil NDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... /CNW/ - The issue: Health ... at Art Nails Ltd., located at 751 Helmcken St., ... contained no labelling. All products administered by injection in ... have approved labelling. The store owner claimed ... risks associated with injecting an unauthorized version of a health product ...
(Date:3/3/2015)... , March 3, 2015   ... and 240 patients respectively Publications in peer ... of Clinical Gastroenterology highlight diagnostic value of confocal ... China and across Asia ... Technologies (Euronext: MKEA, FR0010609263), inventor of Cellvizio®, the multidisciplinary ...
(Date:3/3/2015)... Research and Markets ( http://www.researchandmarkets.com/research/x5lz9r/global_poc ) ... Diagnostics Market 2015-2019" report to their offering. ... Diagnostics market to grow at a CAGR of 8.47 ... diagnostics are IVD devices and tools used for diagnosing ... use of these devices helps in the rapid diagnosis ...
Breaking Medicine Technology:Advisory - Health product seized from Art Nails in Vancouver 2Two New Publications From Leading Team in China Present Data From Large Clinical Trials Highlighting Advantages of Cellvizio in Diagnosis of Gastric and Esophageal Cancers 2Two New Publications From Leading Team in China Present Data From Large Clinical Trials Highlighting Advantages of Cellvizio in Diagnosis of Gastric and Esophageal Cancers 3Two New Publications From Leading Team in China Present Data From Large Clinical Trials Highlighting Advantages of Cellvizio in Diagnosis of Gastric and Esophageal Cancers 4Global POC Diagnostics Market 2015-2019 with Abbott Labs, Alere, Bayer Healthcare, Danaher, F. Hoffmann-La Roche & Johnson & Johnson Dominating 2
... Inc.,(Nasdaq: ITMN ) today announced that it ... pirfenidone in idiopathic pulmonary fibrosis (IPF) prior,to market open ... conference,call and webcast, with accompanying slide presentation, to discuss ... a.m. PST) on Tuesday,February 3. , ...
... led by Laurie Ozelius, Ph.D. at Mount Sinai School ... development of primary torsion dystonia, also known as DYT6 ... Research Foundation (DMRF), Dr. Ozelius and her colleagues have ... dystonia in Amish-Mennonite families, as well as in other ...
Cached Medicine Technology:InterMune to Announce Results of Phase 3 CAPACITY Program of Pirfenidone in IPF Tomorrow, February 3 2Genetic Research Leads to New Discovery in Understanding Rare Neurological Disorder 2
(Date:3/3/2015)... New York, NY (PRWEB) March 03, 2015 ... sleepy this spring. Sanjeev Kothare, MD, has tips for parents. ... tired come March 8 at 2:00 a.m. when they set ... because when you wake up that day -- one hour ... sleep. , That’s why parents should start thinking about “sleep ...
(Date:3/3/2015)... Sunday, March 1, through Saturday, March 7, ... of year, every region of the country is at risk ... Amica Insurance is sharing the following tips from the ... keep you safe in the event of severe weather: , ... clothing frequently to prevent loss of body heat. Wear warm, ...
(Date:3/3/2015)... 2015 -- vRad ( Virtual Radiologic ), the nation’s ... Arlene Sussman, MD, a highly regarded breast imaging and ... explore how telemedicine best practices allow for the access ... virtually anywhere. Click here to register for ... 4, 2015 at 1:00 pm CT. , Hospitals must ...
(Date:3/3/2015)... March 03, 2015 Splashtop Inc. ... announces Mirroring360 is now available for Epson® MoverioTM BT-200 ... the Moverio Apps Market , iPod, iPhone, and ... experience to the Epson Moverio smart glasses using Mirroring360, ... , The Epson smart glasses have an ...
(Date:3/3/2015)... 2015 According to a new ... market saturation has made neurosurgery navigation system procedures ... States. Unit sales growth moderately increased in 2014, ... replace older systems, and as new technology becomes ... very much a replacement and upgrade market,” explains ...
Breaking Medicine News(10 mins):Health News:Don’t Let Daylight Savings Disrupt Your Child’s Sleep 2Health News:Amica Insurance Has Tips for National Severe Weather Preparedness Week 2Health News:Latest vRad Webinar: Building World-Class Breast Imaging Services Virtually Anywhere with Telemedicine Best Practices 2Health News:Latest vRad Webinar: Building World-Class Breast Imaging Services Virtually Anywhere with Telemedicine Best Practices 3Health News:Latest vRad Webinar: Building World-Class Breast Imaging Services Virtually Anywhere with Telemedicine Best Practices 4Health News:Splashtop’s Mirroring360 Now Available for Epson® MoverioTM BT-200 Smart Glasses, Enabling Viewing of iOS Apps and Content on Glasses 2Health News:Splashtop’s Mirroring360 Now Available for Epson® MoverioTM BT-200 Smart Glasses, Enabling Viewing of iOS Apps and Content on Glasses 3Health News:Neurosurgery Navigation System Market Reaches Saturation in the United States 2Health News:Neurosurgery Navigation System Market Reaches Saturation in the United States 3
... ... Certified® 2011with Five Stars for Usability. , ... New York, NY (PRWEB) April 25, 2010 -- CureMD Corporation, ... and revenue cycle service, announced today that CureMD EHR V10 has earned its designation ...
... INDIANAPOLIS Less than a quarter of Americans want no ... the president last month but there may be more common ... latest national survey by researchers from Indiana University,s Center for ... respondents were asked how they viewed the new law:, ...
... ... , ... -- In a recent issue of March 19 India abroad featured Dr. Rajesh Khanna, ... Refractive Surgery. In the article India Abroad praised Khanna for his considerable success in the ...
... ... Task Force to explore possible impacts of desalination in the Arabian Gulf and make ... Steering Committee as well as dates for the upcoming Environmental Symposium in Bahrain. ... (PRWEB) April 24, ...
... ... star for her work on behalf of Parkinson,s research , ... East Islip, NY (PRWEB) April 24, 2010 -- The ... and a person afflicted by the disease who have come together to find a cure at ...
... ... ... 2010 -- It,s a fact that older people have sex. It,s also a fact that ... school when they were growing up. With the advent of male enhancement medications, an increase ...
Cached Medicine News:Health News:CureMD EHR V10 CCHIT Certified 2011with Five Stars for Usability 2Health News:More common ground in health care reform law disagreement than meets the eye 2Health News:India Abroad Features Americas Top Ophthalmologist Rajesh Khanna 2Health News:India Abroad Features Americas Top Ophthalmologist Rajesh Khanna 3Health News:International Desalination Association Announces Members of Environmental Task Force and Dates for Environmental Symposium 2Health News:International Desalination Association Announces Members of Environmental Task Force and Dates for Environmental Symposium 3Health News:International Desalination Association Announces Members of Environmental Task Force and Dates for Environmental Symposium 4Health News:International Desalination Association Announces Members of Environmental Task Force and Dates for Environmental Symposium 5Health News:International Desalination Association Announces Members of Environmental Task Force and Dates for Environmental Symposium 6Health News:International Desalination Association Announces Members of Environmental Task Force and Dates for Environmental Symposium 7Health News:Emmy-Award Winning Actress Susan Lucci to Receive Philanthropic Leadership Award at 7th Annual Cure for Sure Dinner 2Health News:Emmy-Award Winning Actress Susan Lucci to Receive Philanthropic Leadership Award at 7th Annual Cure for Sure Dinner 3Health News:JustGetTested.com Recommends Confidential Blood Testing During Sexually Transmitted Disease (STD) Awareness Month (April) 2Health News:JustGetTested.com Recommends Confidential Blood Testing During Sexually Transmitted Disease (STD) Awareness Month (April) 3
The iQ200 Automated Urinalysis System (iQ System) is a user-friendly, bench top, fully automated system that performs complete urinalyses on unspun specimens; simply load, press START and walk away....
... the C6 peptide antigen, a 26 amino acid ... peptide has been shown to represent the immunodominant ... antigenic reactivity of the whole protein. Recent ... a sensitive and specific marker for antibody to ...
A flexible hematology platform:, 32 parameters, Automatic result validation, Cytology atlas included, CBC and 5+3 DIFF...
... 3W L.E.D. is mounted coaxially on the ... lithium battery pack giving 4 hours continuous ... packs and a charging unit that can ... well as being a convenient container to ...
Medicine Products: